Autres langues

13/08 UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2026
27/04 UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
12/08/25 UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2025
30/04/25 UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
13/08/24 UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2024
18/04/24 UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
11/08/23 UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
21/04/23 UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
15/08/22 UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
29/04/22 UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
29/04/22 UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
16/08/21 Medigen Vaccine Biologics : Taiwan rejects COVID vaccine candidate, president to get domestic shot
16/08/21 Medigen Vaccine Biologics : Taiwan denies approval for UBI's COVID-19 vaccine candidate
13/08/21 Ubi Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2021
13/04/21 UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
11/08/20 Ubi Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2020
08/04/20 Ubi Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
13/08/19 Ubi Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2019
24/04/19 Ubi Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2018
13/01/17 Securities and Futures Investors Protection Center and Jih Sun Securities Co., Ltd. cancelled the acquisition of 1.36% stake in United BioPharma, Inc. from Jih Sun Financial Holding Co., Ltd..
13/01/16 Securities and Futures Investors Protection Center and Jih Sun Securities Co., Ltd. agreed to acquire 1.36% stake in UBI Pharma Inc. from Jih Sun Financial Holding Co., Ltd. for TWD 83.8 million.
Aucun résultat pour cette recherche